简报 口服抗衰 抗衰低龄化趋势显著，口服抗衰迎来升级革命 概览标签：口服抗衰、新兴抗衰成分 China Oral anti-aging 中国経口抗衰産業 报告提供的任何内容（包括但不限于数据、文字、图表、图像等）均系头豹研究院独有的高度机密性文件（在报告中另 行标明出处者除外）。未经头豹研究院事先书面许可，任何人不得以任何方式擅自复制、再造、传播、出版、引用、改 编、汇编本报告内容，若有违反上述约定的行为发生，头豹研究院保留采取法律措施、追究相关人员责任的权利。头豹 研究院开展的所有商业活动均使用"头豹研究院"或"头豹"的商号、商标，头豹研究院无任何前述名称之外的其他分支机构 ，也未授权或聘用其他任何第三方代表头豹研究院开展商业活动。 头豹研究院 1 Chapter 1 口服抗衰 行业综述 www.leadleo.com 400-072-5588 2 ❑ 定义及分类 ❑ 消费者洞察 ❑ 市场参与者 ❑ 发展趋势 简报 | 2025/09 口服抗衰 口服抗衰的定义及分类 3 抗衰需求已从"中老年专属"向全年龄段渗透。口服抗衰指的是通过口服特定 营养成分、生物活性物质，辅助调节体内生理机制、延缓细胞老化，进而维 ...

简报 口服抗衰 抗衰低龄化趋势显著，口服抗衰迎来升级革命 概览标签：口服抗衰、新兴抗衰成分 China Oral anti-aging 中国経口抗衰産業 报告提供的任何内容（包括但不限于数据、文字、图表、图像等）均系头豹研究院独有的高度机密性文件（在报告中另 行标明出处者除外）。未经头豹研究院事先书面许可，任何人不得以任何方式擅自复制、再造、传播、出版、引用、改 编、汇编本报告内容，若有违反上述约定的行为发生，头豹研究院保留采取法律措施、追究相关人员责任的权利。头豹 研究院开展的所有商业活动均使用"头豹研究院"或"头豹"的商号、商标，头豹研究院无任何前述名称之外的其他分支机构 ，也未授权或聘用其他任何第三方代表头豹研究院开展商业活动。 头豹研究院 1 Chapter 1 口服抗衰 行业综述 来源：食研汇、头豹研究院 www.leadleo.com 400-072-5588 2 ❑ 定义及分类 ❑ 消费者洞察 ❑ 市场参与者 ❑ 发展趋势 简报 | 2025/09 口服抗衰 口服抗衰的定义及分类 抗衰需求已从"中老年专属"向全年龄段渗透。口服抗衰指的是通过口服特定 营养成分、生物活性物质，辅助调节体内生理机制、 ...

简报 口服抗衰 抗衰低龄化趋势显著，口服抗衰迎来升级革命 概览标签：口服抗衰、新兴抗衰成分 China Oral anti-aging 中国経口抗衰産業 报告提供的任何内容（包括但不限于数据、文字、图表、图像等）均系头豹研究院独有的高度机密性文件（在报告中另 行标明出处者除外）。 ，任何人不得以任何方式擅自复制、再造、传播、出版、引用、改 编、汇编本报告内容，若有违反上述约定的行为发生，头豹研究院保留采取法律措施、追究相关人员责任的权利。头豹 研究院开展的所有商业活动均使用"头豹研究院"或"头豹"的商号、商标，头豹研究院无任何前述名称之外的其他分支机构 ，也未授权或聘用其他任何第三方代表头豹研究院开展商业活动。 头豹研究院 1 Chapter 1 口服抗衰 行业综述 衰老的标志 基因组不稳定性 端粒磨损 表观遗传改变 蛋白质稳态丧失 菌群失调 营养感应失调 线粒体功能障碍 细胞衰老 细胞自噬失能 细胞间通讯改变 慢性炎症 细胞外基质变化 心理-社会隔离 干细胞耗竭 衰老引发的常见疾病 眼部疾病 听力损失 皮肤衰老 心脑血管疾病 神经退行性变 代谢系统疾病 呼吸系统疾病 泌尿系统疾病 生殖系统疾病 骨骼关节疾病 ...

行业简报 电力巡检无人机行业深度报告： 智能电网时代的平台化演进 深度分析电力巡检无人机行业， 将如何推进智能电网时代的平台化？ 报告提供的任何内容（包括但不限于数据、文字、图表、图像等）均系头豹研究院独有的高度机密性文件（在报告中另 行标明出处者除外）。 ，任何人不得以任何方式擅自复制、再造、传播、出版、引用、改 编、汇编本报告内容，若有违反上述约定的行为发生，头豹研究院保留采取法律措施、追究相关人员责任的权利。头豹 研究院开展的所有商业活动均使用"头豹研究院"或"头豹"的商号、商标，头豹研究院无任何前述名称之外的其他分支机构 ，也未授权或聘用其他任何第三方代表头豹研究院开展商业活动。 头豹研究院 1 行业研读 | 2025/02 Chapter 1 行业综述：电力巡检无 人机演进背景 ❑ 定义与核心价值：从"飞行工具"到"诊断平台"的范式革命 ❑ 政策与技术双驱动：低空经济与新型基建的共振 ❑ 市场规模与增长动能：百亿蓝海的爆发曲线 www.leadleo.com 400-072-5588 2 行业研读 | 2025/09 电力巡检无人机 为什么无人机需要从"飞行工具"升级为"诊断平台"？ • 升级源于电 ...

www.leadleo.com 2025年中国生物创新药市场跟踪报告： 呋喹替尼8月市场动向 2025 China Biopharmaceutical Innovation Market Tracking Report: Market Trends for Fitinib in August 2025年中国バイオ医薬品イノベーション市場追跡レポート：月時点のフィチニブ市場動向 概览标签：呋喹替尼、结直肠癌、和黄医药 作者：何婉怡 报告提供的任何内容（包括但不限于数据、文字、图表、图像等）均 系头豹研究院独有的高度机密性文件（在报告中另行标明出处者除外 、再造、传播、出版、引用、改编、汇编本报告内容，若有违反上述 约定的行为发生，头豹研究院保留采取法律措施，追究相关人员责任 的权利。头豹研究院开展的所有商业活动均使用"头豹研究院"或"头豹 "的商号、商标，头豹研究院无任何前述名称之外的其他分支机构， 也未授权或聘用其他任何第三方代表头豹研究院开展商业活动。 1 ©2025 LeadLeo ）。 ，任何人不得以任何方式擅自复制 www.leadleo.com 400-072-5588 #6C0000 #7C000 ...

Investment Rating - The report does not explicitly state an investment rating for the industry or SpaceX Core Insights - SpaceX is recognized as a leading representative in the commercial space industry, with unique advantages such as vertical integration, cost control, and a supportive government-business collaboration model [2][3][4][5][8][12][29] Summary by Sections SpaceX's Competitive Advantages - SpaceX's vertical integration allows it to produce 85% of its core components in-house, enhancing quality control and reducing costs compared to competitors that rely on outsourcing [3] - The company has pioneered reusable rocket technology, significantly lowering launch costs to $3,000 per kilogram, compared to the global average of $10,000 to $20,000 per kilogram [4] - The Starlink project has created a closed-loop ecosystem, providing continuous demand for rocket launches while generating substantial revenue, with Starlink contributing approximately $4.178 billion to SpaceX's total revenue of around $8 billion in 2023 [5][12] Government Support and Collaboration - SpaceX has received over $15 billion in government contracts from NASA and the U.S. Department of Defense, which have been crucial for its development and financial stability [8][20] - NASA has provided extensive technical support and access to critical data, which has been instrumental in SpaceX's rapid technological advancements [21][22] - The U.S. government has established policies that favor commercial space ventures, allowing SpaceX to operate in a more favorable regulatory environment compared to its competitors [23][29] Financing and Market Position - SpaceX has demonstrated exceptional financing capabilities, raising over $10 billion through various channels, including equity financing and government contracts [12] - The company has a strong user base for Starlink, with over 4 million subscribers, contributing to its cash flow and enabling further technological development [12] - The report highlights the challenges faced by Chinese private space companies in replicating SpaceX's success due to differences in technology, policy environment, and capital market maturity [15][16] Chinese Commercial Space Industry - China's commercial space policies have gradually improved since 2015, but significant barriers remain, particularly in financing and access to critical resources [34][41] - The report notes that while there are over 400 commercial space companies in China, most are private, and many face challenges in rocket manufacturing and deployment [34] - The demand for satellite deployment in China is increasing, with plans to launch over 15,318 satellites by 2027, indicating a growing market potential [36][38]

Investment Rating - The report does not explicitly state an investment rating for the industry or SpaceX Core Insights - SpaceX is recognized as a leading representative in the commercial space industry, with unique advantages such as vertical integration, cost control, and a supportive government-business collaboration model [2][3][4][5][8][12][29] Summary by Sections Vertical Integration and Cost Control - SpaceX's vertical integration allows it to produce 85% of its core components in-house, including engines and electronic systems, which enhances quality control and reduces production costs [3] - The Falcon 9 rocket's reusability has significantly lowered launch costs to $3,000 per kilogram, compared to the global average of $10,000 to $20,000 per kilogram [4] Starlink Project - The Starlink project has created a global broadband network with over 5,000 LEO satellites, generating approximately $4.178 billion in revenue for SpaceX in 2023, making it the largest revenue source for the company [5] Government Support - SpaceX has received over $15 billion in government contracts from NASA and the U.S. Department of Defense from 2006 to 2021, which has been crucial for its technology development and financial stability [8][20] - NASA has provided extensive technical support and access to facilities, which has been vital for SpaceX's rapid development [21][22] Financing Capabilities - SpaceX has raised over $10 billion through diverse financing methods, including equity financing and government contracts, with significant investments from major firms like Sequoia Capital and Google [12][29] Talent Pool - SpaceX employs over 13,000 engineers and high-end manufacturing talent, fostering a culture of rapid technological innovation [14] Replicability of SpaceX's Model - The replicability of SpaceX's business model is constrained by factors such as technological capabilities, policy environments, and the maturity of capital markets [15][16] Challenges in China's Commercial Space Sector - China's commercial space policies have been gradually improving since 2015, but significant barriers remain, particularly in financing and access to key resources [34][41] - The approval process for private enterprises is lengthy and complex, limiting their ability to participate in government contracts and core tasks [35][40]

Product Launch Highlights - The iPhone 17 series includes four models: iPhone 17, iPhone 17 Air, iPhone 17 Pro, and iPhone 17 Pro Max, covering a price range from 6000 to over 10,000 yuan[2] - iPhone 17 targets the mass market with a focus on cost-effectiveness, while iPhone 17 Air emphasizes its ultra-thin design at 5.6mm[2] - The Pro models focus on imaging and computational power upgrades, catering to professional creators and high-end consumers[2] Apple Watch Series Update - Apple launched three new models: Apple Watch SE3, Series 11, and Ultra 3, enhancing health management and fitness tracking capabilities[4] - SE3 is positioned as an entry-level model, Series 11 targets mainstream health management, and Ultra 3 is aimed at high-end outdoor and extreme sports users[4] AirPods Pro 3 Enhancements - The new AirPods Pro 3 features a 67% improvement in noise cancellation and adds heart rate monitoring and hearing detection capabilities[6] Supply Chain Diversification - Apple is shifting towards a global distributed manufacturing model, with the iPhone 17 series being produced in India for the first time, marking a significant change in its supply chain strategy[9] - In Q2 2025, 44% of smartphones assembled in India were for the U.S. market, up from 13% year-on-year, with nearly 80% of U.S. iPhones produced in India[11] Manufacturing Cost and Infrastructure - Manufacturing costs in India are 5%-10% higher than in China, and challenges remain in infrastructure and supply chain stability[11] - China is transitioning to a high-value manufacturing hub, focusing on core components while India handles mid-range assembly[14] AI Functionality and Competitive Landscape - Apple introduced the Apple Intelligence system, integrating AI features across multiple devices, but the rollout is cautious and limited to specific models and regions[20] - Compared to competitors like Samsung and Huawei, Apple lags in the breadth of AI applications and ecosystem integration, which may impact user engagement[26] Supply Chain Impact from AI - The push for AI functionality necessitates upgrades in chip performance, storage, and sensor quality, creating new opportunities for suppliers[28] - Suppliers must meet higher technical standards to secure contracts, emphasizing the importance of privacy and data security in component design[28]

Investment Rating - The report recommends investment in the shingles vaccine industry, highlighting its growth potential driven by aging population and chronic disease burden [1]. Core Insights - The shingles vaccine market in China is entering an accelerated cultivation phase due to the expansion of the elderly population, increased awareness of pain and complications, and improvements in adult immunization services [4]. - The market is transitioning from a single high-end supply model to a layered supply and multi-scenario penetration approach, with a focus on commercial capabilities such as channel coverage and service efficiency [4]. - The industry is expected to grow significantly, with the market size projected to reach 56.68 billion yuan by 2030, growing at a compound annual growth rate (CAGR) of 29.08% from 2024 [9]. Market Background - The shingles vaccine industry is defined as encompassing the development of antigens and adjuvants, production quality management, cold chain logistics, vaccination services, and public health education [5]. - The industry has evolved from the initial development of live attenuated vaccines to the emergence of recombinant subunit vaccines, leading to a diversified and upgraded market structure [6][7]. Market Status - The market size for shingles vaccines in China was 3.998 billion yuan in 2024, with a significant increase in demand driven by the aging population and chronic disease burden [9][10]. - The introduction of high-efficacy vaccines like GSK's Shingrix has created a new consumption category, while domestic vaccines like Changchun Baku's live attenuated vaccine have entered the market, marking a dual-product competition era [9]. Market Competition - The competitive landscape features a tiered structure, with leading companies including Baike Biological, Jifei Biological, and Jiachen Xihai, while others like Lvzhu Biological and Ruike Biological follow [17][21]. - The report emphasizes the importance of product and technology platform positioning, supply chain certainty, and commercialization capabilities in determining competitive advantages [13][14][15]. Development Trends - The aging trend and immune decline are expected to drive sustained demand for adult vaccinations, with the elderly population projected to exceed 400 million by 2035 [32]. - The self-paid nature of shingles vaccines influences market penetration, with domestic vaccines offering more accessible pricing compared to imported options [33]. - The evolution of vaccination channels and service systems, including integrated vaccination networks and digital follow-ups, is crucial for improving vaccination completion rates [34]. - The internationalization of vaccine manufacturing and supply chain capabilities will play a significant role in the future development of the industry [35].

行业简报 东盟人工智能行业研究： 全球竞争下的发展胜势 企业标签：领创集团、VNG科技 头豹研究院 头豹研究院 1 行业研读 | 2025/08 www.leadleo.com 400-072-5588 2 ◆ 东盟数字经济框架协议：由东盟主导的区域性协议，旨在通过减少地区数字政策的碎片化，推动区域 内人工智能政策的整合。一旦生效，该协议有望将东盟数字产业的潜在规模提升至2万亿美元。 ◆ 南A中心："中国—东盟人工智能创新合作中心"的简称 。该中心是推动中国与东盟在人工智能领域合 作的核心平台，旨在集聚国内外的AI技术、企业和人才，开展前沿技术研发与创新，并推动AI技术在 各领域的广泛应用。 ◆ 数字主权：指一个国家对其境内的数字数据、网络基础设施和数字技术拥有独立自主的管辖权和控制 权。在文稿中，这体现在推动建立跨境数据流动的安全保障机制时，需要基于对各国数字主权的尊重。 ◆ "政策磁场"：一个比喻性说法，指通过多个区域性政策的叠加，形成了一个对特定产业（此处指人工 智能产业）极具吸引力的政策环境 。在文稿中，南宁市通过叠加多项红利政策，为AI产业发展提供了 坚实保障。 行业研读 | 2025/08 东盟人 ...